Libtayo
- Featured
Featured
Frequently Asked Questions
Libtayo is a cutting-edge immunotherapy drug that has revolutionized the way cancer is treated.The monoclonal antibody treatment, referred to by its generic name, cemiplimab, was created by top pharmaceutical corporations.
Advanced cutaneous squamous cell carcinoma: Irradiation therapy can be used to treat advanced CSCC, a kind of skin cancer that arises from squamous cells in the skin.
Advanced basal cell carcinoma: Additionally, it is used to treat advanced BCC, a form of skin cancer that appears in the skin’s basal cells.
Non-small cell Lung cancer: It is a prescription medication used in combination therapy to treat adults with non-small cell lung cancer.
Cervical cancer: It has been approved for treating adult cervical cancer that has spread or returned.
Here are a few typical examples:
- Skin reactions
- Weakness
- Diarrhea and nausea
- Fever
- Reduced appetite
- Thyroid disorders
- Joint pain
It’s crucial to talk about these factors before beginning treatment.
- Immune-related side effects
- Thyroid disease
- Renal dysfunction and immune-mediated nephritis
- Liver issues
- Pneumonitis with an immune element
- Pregnancy and breastfeeding
- Pre-existing conditions